European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

  1. Zinzani, P.L.
  2. Karlin, L.
  3. Radford, J.
  4. Caballero, D.
  5. Fields, P.
  6. Chamuleau, M.E.D.
  7. D’Amore, F.
  8. Haioun, C.
  9. Thieblemont, C.
  10. González-Barca, E.
  11. Grande García, C.
  12. Johnson, P.W.
  13. Van Imhoff, G.W.
  14. Ng, T.
  15. Dwyer, K.
  16. Morschhauser, F.
Aldizkaria:
Haematologica

ISSN: 1592-8721,  0390-6078

Argitalpen urtea: 2016

Alea: 101

Zenbakia: 10

Orrialdeak: e407-e410

Mota: Gutuna

DOI: 10.3324/HAEMATOL.2016.146977 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus